Trigeminal neuralgia: IncobotulinumtoxinA (Xeomin), can it decrease the pharmacological intervention? (A case series)

• Asıl Yazarlar: Meghdad Hosseini (Yazar), Farhad Asarzadegan (Yazar), Erfan Shafiee (Yazar), Shayan Alijanpour (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Babol University of Medical Sciences, 2023-03-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Background: Trigeminal neuralgia is one of the most disabling facial pain syndromes. In recent years' new therapeutic strategy, incobotulinumtoxin A has emerged. The aim of the current study was to determine the time and duration of pain in 3 cases with pharmacological treatment and incobotulin...